首页> 外文期刊>Life sciences >Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib
【24h】

Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib

机译:oxysophocarpine抑制FGFR1过表达的肝细胞癌生长,并敏感Lenvatinib的治疗效果

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Hepatocellular carcinoma (HCC) is an aggressive solid tumor with restricted therapeutics. Lenvatinib is the second approved frontline drug for advanced HCC, however lenvatinib-resistant cases have been reported in clinical. Overexpression of fibroblast growth factor receptor (FGFR1) has been found to be associated with advanced HCC. This study was aimed to investigate the relationship between FGFR1 overexpression and lenvatinib resistance, and explore the potential candidate that can sensitize lenvatinib against FGFR1-overexpressed HCC.
机译:目的:肝细胞癌(HCC)是一种侵袭性实体瘤,治疗手段有限。伦伐替尼是第二种获准用于晚期肝癌的一线药物,但临床上已有伦伐替尼耐药病例报告。已发现成纤维细胞生长因子受体(FGFR1)的过度表达与晚期肝癌相关。本研究旨在研究FGFR1过度表达与lenvatinib耐药性之间的关系,并探索lenvatinib对FGFR1过度表达HCC的潜在致敏候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号